Furthermore, the DNA integrity was not significantly different based on the clinical variables in newly diagnosed NB patients, including age, sex, clinical stages, MYCN amplification, metastasis, etc. The differences in DNA integrity between primary tumor sites and between tumor volumes were significant in newly diagnosed NB patients (Table 5). The gene discussed is MYCN; the disease is neoplasm.